Cargando…
Formulation, Characterization, and in Vivo Evaluation of Celecoxib-PVP Solid Dispersion Nanoparticles Using Supercritical Antisolvent Process
The aim of this study was to develop celecoxib-polyvinylpyrrolidone (PVP) solid dispersion nanoparticles with and without surfactant using the supercritical antisolvent (SAS) process. The effect of different surfactants such as gelucire 44/14, poloxamer 188, poloxamer 407, Ryoto sugar ester L1695, a...
Autores principales: | Ha, Eun-Sol, Choo, Gwang-Ho, Baek, In-Hwan, Kim, Min-Soo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6271652/ https://www.ncbi.nlm.nih.gov/pubmed/25486246 http://dx.doi.org/10.3390/molecules191220325 |
Ejemplares similares
-
Development of megestrol acetate solid dispersion nanoparticles for enhanced oral delivery by using a supercritical antisolvent process
por: Ha, Eun-Sol, et al.
Publicado: (2015) -
Enhanced bioavailability of sirolimus via preparation of solid dispersion nanoparticles using a supercritical antisolvent process
por: Kim, Min-Soo, et al.
Publicado: (2011) -
Formation of Fine Particles
from Curcumin/PVP by the
Supercritical Antisolvent Process with a Coaxial Nozzle
por: Machmudah, Siti, et al.
Publicado: (2020) -
Fabrication and evaluation of valsartan–polymer– surfactant composite nanoparticles by using the supercritical antisolvent process
por: Kim, Min-Soo, et al.
Publicado: (2014) -
Preparation and characterization of celecoxib solid dispersions; comparison of poloxamer-188 and PVP-K30 as carriers
por: Homayouni, Alireza, et al.
Publicado: (2014)